Literature DB >> 5033082

Lung damage in mice following intraperitoneal injection of butylated hydroxytoluene.

A A Marino, J T Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5033082     DOI： 10.3181/00379727-140-36407

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  8 in total

1.  Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation.

Authors:  Elizabeth F Redente; David M Higgins; Lori D Dwyer-Nield; Ian M Orme; Mercedes Gonzalez-Juarrero; Alvin M Malkinson
Journal:  J Leukoc Biol       Date:  2010-04-01       Impact factor: 4.962

2.  Effect of butylated hydroxytoluene and paraquat on urethan tumorigenesis in mouse lung.

Authors:  F Boján; A Nagy; K Herman
Journal:  Bull Environ Contam Toxicol       Date:  1978-10       Impact factor: 2.151

3.  DNA cleavage by metabolites of butylated hydroxytoluene.

Authors:  F Nagai; K Ushiyama; I Kano
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

4.  Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation.

Authors:  D Balli; X Ren; F-S Chou; E Cross; Y Zhang; V V Kalinichenko; T V Kalin
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

Review 5.  Implications of post-pneumonectomy compensatory lung growth in pulmonary physiology and disease.

Authors:  L M Brown; S R Rannels; D E Rannels
Journal:  Respir Res       Date:  2001-08-21

Review 6.  The role of toxicological interactions in lung injury.

Authors:  H P Witschi; P J Hakkinen
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

7.  Promotion of lung tumors in mice.

Authors:  H P Witschi
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

Review 8.  Understanding the mechanisms of drug-associated interstitial lung disease.

Authors:  T Higenbottam; K Kuwano; B Nemery; Y Fujita
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.